COMPREHENSIVE (LOSS) INCOME (Schedule of Changes in Accumulated Other Comprehensive Income by Component (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2014		Sep. 30, 2013	Jun. 30, 2013	Dec. 31, 2012
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated Other Comprehensive Income Loss Cumulative Changes In Net Gain Loss From Cash Flow Hedge Effect Before Tax	$ (2,772)			$ (2,772)	$ (2,868)	$ (4,159)
Accumulated Other Comprehensive Income (Loss) [Roll Forward]
Beginning balance		927	[1]
Other comprehensive income (loss) before reclassifications		(16,002)
Amounts reclassified from accumulated other comprehensive income		757
Net current-period other comprehensive income (loss)		(15,245)
Ending balance		(14,318)
Derivative Instruments, Gain (Loss) Recognized in Other Comprehensive Income (Loss), Effective Portion, Net	(277)			(17)
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net	(373)			(1,404)
Gains and Losses on Cash Flow Hedges
Accumulated Other Comprehensive Income (Loss) [Roll Forward]
Beginning balance		(1,390)
Other comprehensive income (loss) before reclassifications		(102)
Amounts reclassified from accumulated other comprehensive income		757
Net current-period other comprehensive income (loss)		655
Ending balance		(735)
Defined Benefit Pension Items
Accumulated Other Comprehensive Income (Loss) [Roll Forward]
Beginning balance		(2,287)
Other comprehensive income (loss) before reclassifications		52
Amounts reclassified from accumulated other comprehensive income		0
Net current-period other comprehensive income (loss)		52
Ending balance		(2,235)
Foreign Currency Items
Accumulated Other Comprehensive Income (Loss) [Roll Forward]
Beginning balance		4,604
Other comprehensive income (loss) before reclassifications		(15,952)
Amounts reclassified from accumulated other comprehensive income		0
Net current-period other comprehensive income (loss)		(15,952)
Ending balance		$ (11,348)

[1] See Note 1 of these condensed consolidated financial statements for discussion of the impact of the change in accounting for the medical device excise tax.